UCI Anti-Cancer Challenge
The UC Irvine Anti-Cancer Challenge is a community movement to raise awareness and funds for critical cancer research at the UCI Health Chao Family Comprehensive Cancer Center and CHOC, part of Rady Children’s Health.
Every participant-raised dollar directly funds pilot studies and early phase clinical trials that aim to develop new insights into cancer prevention, treatment and cures — to save lives.
The UC Irvine Anti-Cancer Challenge is an activity of the University of California, Irvine Foundation, a 501(c)(3) nonprofit, tax ID 95-2540117.
Thank you for helping to raise over $1.1 million for critical cancer research!
Every dollar will directly fund innovative research aimed at cancer prevention, treatments and cures at the UCI Health Chao Family Comprehensive Cancer Center and CHOC, part of Rady Children's Health. The announcement of pilot projects and early phase clinical trials funded by your contributions will be announced next year! Please stay tuned for updates!
Relive your favorite Challenge Day moments by watching the 2025 event recap video, showcasing the unity and passion of the UC Irvine Anti-Cancer Challenge community.
Save the date for the Anti-Cancer Challenge 10-year anniversary celebration on Saturday, Oct. 10, 2026.
Together, we are leading the charge against cancer.
Making a Difference
The fight against cancer begins with fundamental research on its causes, detection, prevention and treatment at National Cancer Institute (NCI)-designated comprehensive cancer centers like the UCI Health Chao Family Comprehensive Cancer Center. Through a partnership with CHOC, part of Rady Children’s Health, a portion of proceeds are dedicated to pediatric cancer research.
Your support through the Anti-Cancer Challenge directly funds cancer-related projects, enabling UC Irvine physician-scientists to generate crucial preliminary data for high-impact research.
Meet 2025 Patient Honoree - Bransby Whitton
Bransby Whitton discovered a lump in his abdomen in late 2021 on a holiday trip. In early 2022, a biopsy revealed it was an especially aggressive form of non-Hodgkin lymphoma. A friend connected him with UCI Health and within a few days, renowned lymphoma expert Dr. Lauren Pinter-Brown started him on the first of six rounds of primary chemotherapy.
“I feel so fortunate to have found UCI Health and Dr. Pinter-Brown, who gave me world-class care.”
Search
